1296OClinical efficacy of atezolizumab (Atezo) in PD-L1...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

1296OClinical efficacy of atezolizumab (Atezo) in PD-L1 subgroups defined by SP142 and 22C3 IHC assays in 2L+ NSCLC: Results from the randomized OAK study

Gadgeel, S., Kowanetz, M., Zou, W., Hirsch, F.R., Kerr, K.M., Gandara, D.R., Barlesi, F., Park, K., McCleland, M., Koeppen, H., Ballinger, M., Sandler, A., Hegde, P.S., Rittmeyer, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx380.001
Date:
September, 2017
File:
PDF, 127 KB
english, 2017
Conversion to is in progress
Conversion to is failed